This case study examines the ethical challenges involved in analyzing patient records and related texts within health sciences research, particularly when such materials are used in literature analysis across interdisciplinary fields such as education, theology, and the humanities. Patient records, including medical charts, clinical notes, case reports, and illness narratives, contain highly sensitive personal information. Their use raises significant concerns about privacy, consent, and the potential for harm if data are mishandled or inadequately contextualized.
In this scenario, a researcher conducts a literature-based study examining historical and contemporary narratives of chronic illness in order to explore how medical language shapes patient identity and treatment outcomes. The corpus includes published case studies, anonymized clinical records from archives, and patient-authored accounts drawn from medical journals. While the materials are legally accessible, they are closely tied to identifiable individuals and lived experiences.
From a legal standpoint, the researcher must comply with relevant privacy and data protection frameworks governing health information. These regulations typically require safeguards such as de-identification, restricted access, and limits on reproduction or redistribution. Even when records are anonymized or part of the public record, legal compliance alone does not resolve the ethical responsibilities involved in their interpretation and presentation.
Ethically, the use of patient records demands careful attention to dignity, respect, and proportional use. The researcher must consider whether detailed clinical information is necessary for the analytical argument or whether broader thematic analysis would suffice. Quoting or describing medical details that could invite re-identification, reinforce stigma, or sensationalize illness may expose individuals or families to emotional distress or social harm.
This case also highlights the role of consent and expectation. Many patient records were created for clinical or administrative purposes, not for scholarly analysis in the humanities. Patients may not have anticipated that their experiences would be interpreted as literary or cultural texts. Ethical practice therefore involves sensitivity to original context, restraint in interpretation, and, where possible, reliance on materials where authors have knowingly chosen public disclosure.
Risk assessment is central to responsible decision-making in this case. The researcher must evaluate the likelihood of harm, including breaches of confidentiality, misrepresentation of medical conditions, or legal consequences for institutions or individuals. Consulting an IRB or ethics review committee can help clarify whether the project requires formal review and can provide guidance on anonymization, data handling, and dissemination strategies.
The case further illustrates how interdisciplinary research complicates ethical boundaries. When patient records are analyzed not for clinical outcomes but for narrative structure, metaphor, or theological meaning, researchers must take care not to instrumentalize illness for abstract purposes. Ethical literature analysis balances critical insight with humility, acknowledging the limits of interpretation when engaging embodied suffering.
In conclusion, this case study demonstrates that patient records and privacy represent a high-stakes ethical terrain within literature analysis. Responsible engagement requires legal compliance, ethical reflection, and methodological restraint. By prioritizing privacy, consent, and care, researchers can contribute meaningful analysis while upholding respect for persons whose lives are represented in medical texts.
When mapped onto typical IRB or ethics review pathways, this case occupies an ethically ambiguous space that often requires careful institutional judgment. The research relies on texts rather than direct interaction with participants, which may place it under categories such as secondary data analysis or exempt research. However, because the materials involve sensitive health information and are closely connected to identifiable individuals, an ethics review is often advisable.
An IRB would typically ask whether the data include protected health information, whether individuals can reasonably be re-identified, and whether the research poses more than minimal risk. In this case, even anonymized records may carry residual risk due to the specificity of medical details. The review process may therefore recommend enhanced safeguards, including strict anonymization, limited quotation, controlled data storage, and careful framing of interpretive claims.
The IRB pathway may result in an exemption with conditions, expedited review, or full review, depending on jurisdiction and institutional policy. Regardless of the formal outcome, the review process functions as an ethical checkpoint that encourages proportionality, risk mitigation, and clear justification of scholarly need.